Aruanno, Arianna
 Distribuzione geografica
Continente #
NA - Nord America 1.940
EU - Europa 1.880
AS - Asia 1.135
SA - Sud America 180
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 5.158
Nazione #
US - Stati Uniti d'America 1.897
DE - Germania 730
SG - Singapore 504
CN - Cina 355
SE - Svezia 254
IT - Italia 185
UA - Ucraina 145
BR - Brasile 139
FR - Francia 130
PL - Polonia 119
GB - Regno Unito 98
IN - India 81
IE - Irlanda 54
FI - Finlandia 46
VN - Vietnam 41
ID - Indonesia 39
RU - Federazione Russa 28
CA - Canada 27
NL - Olanda 19
AR - Argentina 17
BE - Belgio 15
HK - Hong Kong 14
TR - Turchia 12
CZ - Repubblica Ceca 11
IR - Iran 10
JP - Giappone 10
BD - Bangladesh 9
MX - Messico 9
KR - Corea 8
SA - Arabia Saudita 8
AL - Albania 7
IQ - Iraq 7
PK - Pakistan 7
VE - Venezuela 7
ES - Italia 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
IL - Israele 5
PT - Portogallo 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
MA - Marocco 4
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
EC - Ecuador 3
JM - Giamaica 3
LV - Lettonia 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BG - Bulgaria 2
DK - Danimarca 2
DZ - Algeria 2
KZ - Kazakistan 2
LT - Lituania 2
MY - Malesia 2
PE - Perù 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
TN - Tunisia 2
UY - Uruguay 2
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.158
Città #
Chandler 311
Singapore 249
Ashburn 209
Warsaw 109
Dallas 97
Jacksonville 75
San Mateo 67
Ann Arbor 65
Fairfield 57
Los Angeles 56
Wilmington 56
Dublin 54
Beijing 50
Nanjing 49
New York 47
Milan 42
Woodbridge 40
Marseille 39
Nürnberg 39
The Dalles 35
Hefei 34
Munich 34
Jakarta 33
Houston 28
Seattle 28
Dearborn 27
Frankfurt am Main 27
Rome 26
Redwood City 21
Boston 20
Lawrence 20
Nanchang 20
Buffalo 19
Pune 18
London 17
Moscow 17
Boardman 16
Bremen 15
Ho Chi Minh City 15
Falls Church 14
Brussels 13
Hong Kong 13
Shenyang 13
Cambridge 12
Helsinki 12
Toronto 12
Fremont 11
University Park 11
Düsseldorf 10
São Paulo 10
Brno 9
Changsha 9
Leawood 9
Princeton 9
Tokyo 9
Chicago 8
Hebei 8
Paris 8
Phoenix 8
Stockholm 8
Zhengzhou 8
Bexley 7
Brooklyn 7
Hangzhou 7
Hanoi 7
Izmir 7
Lancaster 7
Menlo Park 7
Montreal 7
Orem 7
Santa Clara 7
Simi Valley 7
Wroclaw 7
Amsterdam 6
Bitonto 6
Kent 6
Lauterbourg 6
Nuremberg 6
Andover 5
Belo Horizonte 5
Porto Alegre 5
San Francisco 5
Seoul 5
Shanghai 5
Tashkent 5
Augusta 4
Baghdad 4
Barquisimeto 4
Brush Creek 4
Charlotte 4
Denver 4
Jiaxing 4
Kunming 4
Makassar 4
Norwalk 4
Ottawa 4
Querétaro 4
Redmond 4
Rio de Janeiro 4
Riyadh 4
Totale 2.614
Nome #
Latex immunotherapy: evidence of effectiveness. 310
Anaphylaxis by antihistamine containing bovine gelatin: the utility of the basophil activation test in the diagnostic work-up. 239
Allergy and psychologic evaluations of patients with multiple drug intolerance syndrome 220
Gene expression profiling of patients with latex and/or vegetable food allergy 211
food allergy and food intolerance: diagnosis and treatment 206
Allergie e intolleranze alimentari 205
lezioni di immunoallergologia 189
The clinical meaning of positive latex sIgE in patients with food/pollen adverse reactions 183
Allergic and non-allergic drug hypersensitivity reactions in children. 177
Sublingual immunotherapy with natural rubber latex: a case report with 8-year follow-up 167
A case of IgE-mediated allergy and cell-mediated allergy to Seaprose-S in the same patient 163
Delayed hypersensitivity to heparin in a patient with cancer: fondaparinux may be safe but needs to be tested 160
Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase 155
Cross-reactivity and tolerability of Ertapenem in patients with IgE-mediated hypersensitivity to β-lactams 154
Utility of Basophil Activation Test for monitoring the acquisition of clinical tolerance after oral desensitization to cow's milk: Pilot study 152
The clinical meaning of positive latex sIgE in patients with food/pollen adverse reactions 147
Cross-reactivity and tolerability of cephalosporins in patients with cell-mediated allergy to penicillins. 146
Profilin desensitization: A case series 144
Tolerability of aztreonam in patients with cell-mediated allergy to beta-lactams. 143
Challenge tests in the diagnosis of latex allergy 141
Profilin desensitization in two patients with plant-derived food allergy 136
Delayed-type hypersensitivity to fenofibrate 133
Apple desensitization in two patients with PR-10 proteins allergy 128
Clinical and quality of life assessment in patients with latex allergy during COVID-19 pandemic: Possible protective role of continuous latex immunotherapy 128
Sublingual desensitization in patients with wasp venom allergy: preliminary results 125
Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy. 119
Desensitization to co-trimoxazole in a patient with fixed drug eruption 119
Peanut allergy in Italy: A unique Italian perspective 113
apple desensitization in two patients with PR-10 proteins allergy 111
'Empty sella syndrome': a case of a patient with sodium succinate hydrocortisone allergy 109
sublingual immunotherapy with venom for patients with Hymenoptera venom allergy 103
The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey 90
Epinephrine Auto-Injector Prescription and Use: A Retrospective Analysis and Clinical Risk Assessment of Adult Patients Sensitized to Lipid Transfer Protein 78
Mollusk allergy in shrimp-allergic patients: Still a complex diagnosis. An Italian real-life cross-sectional multicenter study 74
IgE-mediated allergic reactions to ocrelizumab in multiple sclerosis: A retrospective cohort study 13
Totale 5.191
Categoria #
all - tutte 19.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021198 0 0 0 0 0 16 38 7 39 7 86 5
2021/2022348 42 22 7 14 19 25 6 51 6 18 70 68
2022/2023808 157 109 49 149 39 94 53 39 91 8 11 9
2023/2024377 26 99 5 9 16 74 25 11 4 13 49 46
2024/2025759 28 32 55 28 84 21 8 53 105 68 170 107
2025/20261.036 247 50 195 157 325 62 0 0 0 0 0 0
Totale 5.191